- Home
- DATS vs KLTO Comparison
DATS vs KLTO Comparison
Compare DATS & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DATS
- KLTO
- Stock Information
- Founded
- DATS 2014
- KLTO 2019
- Country
- DATS United States
- KLTO United States
- Employees
- DATS N/A
- KLTO N/A
- Industry
- DATS Computer Software: Prepackaged Software
- KLTO
- Sector
- DATS Technology
- KLTO
- Exchange
- DATS Nasdaq
- KLTO NYSE
- Market Cap
- DATS 9.5M
- KLTO 9.8M
- IPO Year
- DATS 2021
- KLTO N/A
- Fundamental
- Price
- DATS $2.79
- KLTO $0.15
- Analyst Decision
- DATS
- KLTO
- Analyst Count
- DATS 0
- KLTO 0
- Target Price
- DATS N/A
- KLTO N/A
- AVG Volume (30 Days)
- DATS 8.0M
- KLTO 102.6K
- Earning Date
- DATS 05-13-2025
- KLTO 05-15-2025
- Dividend Yield
- DATS N/A
- KLTO N/A
- EPS Growth
- DATS N/A
- KLTO N/A
- EPS
- DATS N/A
- KLTO N/A
- Revenue
- DATS $436.00
- KLTO N/A
- Revenue This Year
- DATS N/A
- KLTO N/A
- Revenue Next Year
- DATS N/A
- KLTO N/A
- P/E Ratio
- DATS N/A
- KLTO N/A
- Revenue Growth
- DATS N/A
- KLTO N/A
- 52 Week Low
- DATS $1.01
- KLTO $0.17
- 52 Week High
- DATS $9.34
- KLTO $13.10
- Technical
- Relative Strength Index (RSI)
- DATS 51.75
- KLTO N/A
- Support Level
- DATS $2.92
- KLTO N/A
- Resistance Level
- DATS $3.39
- KLTO N/A
- Average True Range (ATR)
- DATS 0.60
- KLTO 0.00
- MACD
- DATS 0.05
- KLTO 0.00
- Stochastic Oscillator
- DATS 24.78
- KLTO 0.00
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts, even after they are sent.
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.